Britain approves Pfizer-BioNTech jab for 5-11 age group

Children will receive two 10-microgram doses, a third of the adult dose, with an interval of eight weeks

Credit: Reuters Photo

Britain's medicines regulator on Wednesday approved the use of the Pfizer and BioNTech Covid-19 vaccine for children aged 5 to 11 years, after the watchdog found the shot was safe and effective. The country's vaccines committee advised that children in the age group who were in a clinical risk group should be offered the shot.

The children will receive two 10-microgram doses of the Pfizer-BioNTech vaccine, a third of the adult dose, with an interval of eight weeks between the first and second doses, the Joint Committee on Vaccination and Immunisation said.

Watch the latest DH Videos here: